Internalisation of uncross-linked rituximab is not essential for the induction of caspase-independent killing in Burkitt lymphoma cell lines

Leukemia and Lymphoma

Volumn 49, Issue 8, 2008, Pages 1578-1591

  Turzanski, Julie ^a   Daniels, Ian ^a   Haynes, Andrew P ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Burkitt lymphoma; Caspase independent cell death; CD20; Endocytosis; Internalisation; Rituximab

Indexed keywords

CASPASE; CYTOCHALASIN B; LATRUNCULIN A; PHOSPHATIDYLSERINE; RITUXIMAB;

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CANCER CELL CULTURE; CELL KILLING; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EXPOSURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INHIBITION KINETICS; INTERNALIZATION; LYMPHOMA CELL; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; APOPTOSIS; BIOLOGICAL TRANSPORT; BURKITT LYMPHOMA; CASPASES; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; MICROSCOPY, CONFOCAL;

EID: 51349115692     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802163313     Document Type: Article

References (35)

1. Maloney, D. G., Grillo-Lopez, A. J., White, C. A., Bodkin, D., Schilder, R. J. Neidhart, J. A. et al. (2007) IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood, 90, pp. 2188-2195.
2. Kirchner, E. M., Ebsen, M., Kirchner, J., Theegarten, D. and Voigtmann, R. (2001) Transformation of Hodgkin's disease to high-grade B-cell lymphoma: Remission after rituximab monotherapy. Ann Oncol, 12, pp. 1169-1171.
3. Sacchi, S., Federico, M., Dastoli, G., Fiorani, C., Vinci, G. Clo, V. et al. (2001) Treatment of B-cell non-Hodgkin's lymphoma with anti CD20 monoclonal antibody rituximab. Crit Rev Oncol Hematol, 37, pp. 13-25.
4. Flieger, D., Renoth, S., Beier, I., Sauerbruch, T. and Schmidt-Wolf, I. (2000) Mechanism of cytotoxicity induced by chimeric mouse human monoclonal antibody IDEC-C2B8 in CD20-expressing lymphoma cell lines. Cell Immunol, 204, pp. 55-63.
5. Golay, J., Zaffaroni, L., Vaccari, T., Lazzari, M., Borleri, G. M. Bernasconi, S. et al. (2000) Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis. Blood, 95, pp. 3900-3908.
6. Cragg, M. S. and Glennie, M. J. (2004) Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents. Blood, 103, pp. 2738-2743.
7. Shan, D., Ledbetter, J. A. and Press, O. W. (2000) Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells. Cancer Immunol Immunother, 48, pp. 673-683.
8. Hofmeister, J. K., Cooney, D. and Coggeshall, K. M. (2000) Clustered CD20 induced apoptosis: Src-family kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis. Blood Cells Mol Dis, 26, pp. 133-143.
9. Zhang, N., Khawli, L. A., Hu, P. and Epstein, A. L. (2005) Generation of rituximab polymer may cause hyper-cross-linking-induced apoptosis in non-Hodgkin's lymphomas. Clin Cancer Res, 11, pp. 5971-5980.
10. Bellosillo, B., Villamor, N., Lopez-Guillermo, A., Marce, S., Esteve, J. Campo, E. et al. (2001) Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species. Blood, 98, pp. 2771-2777.
11. van der Kolk, L. E., Evers, L. M., Omene, C., Lens, S. M., Lederman, S. van Lier, R. A. et al. (2002) CD20-induced B cell death can bypass mitochondria and caspase activation. Leukemia, 16, pp. 1735-1744.
12. Chan, H. T., Hughes, D., French, R. R., Tutt, A. L., Walshe, C. A. Teeling, J. L. et al. (2003) CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts. Cancer Res, 63, pp. 5480-5489.
13. Daniels, I., Abulayha, A. M., Thomson, B. J. and Haynes, A. P. (2006) Caspase-independent killing of Burkitt lymphoma cell lines by rituximab. Apoptosis, 6, pp. 1013-1023.
14. Algeciras-Schimnich, A. and Peter, M. E. (2003) Actin dependent CD95 internalization is specific for Type I cells. FEBS Lett, 546, pp. 185-188.
15. Lee, K. H., Feig, C., Tchikov, V., Schickel, R., Hallas, C. Schutze, S. et al. (2006) The role of receptor internalization in CD95 signaling. Embo J, 25, pp. 1009-1023.
16. Sapra, P. and Allen, T. M. (2002) Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs. Cancer Res, 62, pp. 7190-7194.
17. Anolik, J., Looney, R. J., Bottaro, A., Sanz, I. and Young, F. (2003) Down-regulation of CD20 on B cells upon CD40 activation. Eur J Immunol, 33, pp. 2398-2409.
18. Sieber, T., Schoeler, D., Ringel, F., Pascu, M. and Schriever, F. (2003) Selective internalization of monoclonal antibodies by B-cell chronic lymphocytic leukaemia cells. Br J Haematol, 121, pp. 458-461.
19. Jilani, I., O'Brien, S., Manshuri, T., Thomas, D. A., Thomazy, V. A. Imam, M. et al. (2003) Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia. Blood, 102, pp. 3514-3520.
20. Michel, R. B. and Mattes, M. J. (2002) Intracellular accumulation of the anti-CD20 antibody 1F5 in B-lymphoma cells. Clin Cancer Res, 8, pp. 2701-2713.
21. Michel, R. B. and Mattes, M. J. (2004) Antibodies to CD20 and MHC class II antigen bound to B-lymphoma cells accumulate in shed cytoplasmic fragments. Br J Cancer, 91, pp. 1500-1507.
22. Ong, G. L. and Mattes, M. J. (2000) Limitations in the use of low pH extraction to distinguish internalized from cell surface-bound radiolabeled antibody. Nucl Med Biol, 27, pp. 571-575.
23. Munoz-Pinedo, C., Green, D. R. and van den Berg, A (2005) Confocal restricted-height imaging of suspension cells (CRISC) in a PDMS microdevice during apoptosis. Lab Chip, 5, pp. 628-633.
24. Schafer, D. A. (2002) Coupling actin dynamics and membrane dynamics during endocytosis. Curr Opin Cell Biol, 14, pp. 76-81.
25. Ayscough, K. R. (2005) Coupling actin dynamics to the endocytic process in Saccharomyces cerevisiae. Protoplasma, 226, pp. 81-88.
26. Kaksonen, M., Toret, C. P. and Drubin, D. G. (2006) Harnessing actin dynamics for clathrin-mediated endocytosis. Nat Rev Mol Cell Biol, 7, pp. 404-414.
27. Lamaze, C., Fujimoto, L. M., Yin, H. L. and Schmid, S. L. (2007) The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells. J Biol Chem, 272, pp. 20332-20335.
28. Kenis, H., van, Genderen, Deckers, N. M., Lux, P AG, Hofstra, L. Narula, J. et al. (2006) Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches. Exp Cell Res, 312, pp. 719-726.
29. Mateo, V., Brown, E. J., Biron, G., Rubio, M., Fischer, A. Deist, F. L. et al. (2002) Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: Link between phosphatidylserine exposure and cytoskeleton organization. Blood, 100, pp. 2882-2890.
30. Li, J., Li, Q., Xie, C., Zhou, H., Wang, Y. Zhang, N. et al. (2004) β-Actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death. J Cell Sci, 117, pp. 4673-4680.
31. Gourlay, C. W. and Ayscough, K. R. (2005) The actin cytoskeleton: A key regulator of apoptosis and ageing?. Nat Rev Mol Cell Biol, 6, pp. 583-589.
32. Nusco, G. A., Chun, J. T., Ercolano, E., Lim, D., Gragnaniello, G. Kyozuka, K. et al. (2006) Modulation of calcium signalling by the actin-binding protein cofilin. Biochem Biophys Res Commun, 348, pp. 109-114.
33. Soderstrom, T. S., Nyberg, S. D. and Eriksson, J. E. (2005) CD95 capping is ROCK-dependent and dispensable for apoptosis. J Cell Sci, 118, pp. 2211-2223.
34. Chichili, G. R. and Rodgers, W. (2007) Clustering of membrane lipid raft proteins by the actin cytoskeleton. J Biol Chem, 282, pp. 36682-36691.
35. Unruh, T. L., Haidong, L., Mutch, C. M., Shariat, N., Grigoriou, L. Sanyal, R. et al. (2005) Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking. Immunology, 116, pp. 223-232.